Lee Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.91M | Sell |
8,784
-2,147
| -20% | -$476K | 0.27% | 38 |
|
|
2025
Q4 | $2.5M | Sell |
10,931
-1,621
| -13% | -$369K | 0.34% | 28 |
|
|
2025
Q3 | $2.91M | Buy |
12,552
+228
| +2% | +$46.4K | 0.36% | 28 |
|
|
2025
Q2 | $2.29M | Buy |
12,324
+464
| +4% | +$86.2K | 0.33% | 30 |
|
|
2025
Q1 | $2.48M | Sell |
11,860
-1,554
| -12% | -$302K | 0.38% | 25 |
|
|
2024
Q4 | $2.38M | Sell |
13,414
-210
| -2% | -$38.6K | 0.33% | 30 |
|
|
2024
Q3 | $2.69M | Buy |
13,624
+1,379
| +11% | +$257K | 0.38% | 26 |
|
|
2024
Q2 | $2.1M | Sell |
12,245
-599
| -5% | -$99.2K | 0.34% | 26 |
|
|
2024
Q1 | $2.34M | Sell |
12,844
-128
| -1% | -$22.1K | 0.39% | 26 |
|
|
2023
Q4 | $2.01M | Sell |
12,972
-106
| -0.8% | -$15.5K | 0.35% | 28 |
|
|
2023
Q3 | $1.95M | Sell |
13,078
-885
| -6% | -$130K | 0.36% | 29 |
|
|
2023
Q2 | $1.88M | Sell |
13,963
-1,295
| -8% | -$190K | 0.33% | 32 |
|
|
2023
Q1 | $2.43M | Sell |
15,258
-1,482
| -9% | -$227K | 0.42% | 27 |
|
|
2022
Q4 | $2.71M | Buy |
16,740
+168
| +1% | +$25.8K | 0.46% | 27 |
|
|
2022
Q3 | $2.22M | Buy |
16,572
+317
| +2% | +$45.5K | 0.42% | 31 |
|
|
2022
Q2 | $2.49M | Sell |
16,255
-638
| -4% | -$97.5K | 0.46% | 26 |
|
|
2022
Q1 | $2.74M | Sell |
16,893
-1,734
| -9% | -$252K | 0.49% | 29 |
|
|
2021
Q4 | $2.52M | Sell |
18,627
-125
| -0.7% | -$14.8K | 0.47% | 29 |
|
|
2021
Q3 | $2.02M | Buy |
18,752
+307
| +2% | +$35.1K | 0.42% | 30 |
|
|
2021
Q2 | $2.08M | Sell |
18,445
-340
| -2% | -$38.3K | 0.44% | 31 |
|
|
2021
Q1 | $2.03M | Sell |
18,785
-342
| -2% | -$36.6K | 0.48% | 29 |
|
|
2020
Q4 | $2.05M | Buy |
19,127
+106
| +0.6% | +$10.2K | 0.53% | 29 |
|
|
2020
Q3 | $1.67M | Buy |
19,021
+257
| +1% | +$24.2K | 0.47% | 36 |
|
|
2020
Q2 | $1.84M | Sell |
18,764
-147
| -0.8% | -$12.9K | 0.51% | 32 |
|
|
2020
Q1 | $1.44M | Sell |
18,911
-66
| -0.3% | -$5.62K | 0.48% | 36 |
|
|
2019
Q4 | $1.68M | Sell |
18,977
-5
| -0% | -$415 | 0.36% | 36 |
|
|
2019
Q3 | $1.44M | Buy |
18,982
+2,801
| +17% | +$192K | 0.32% | 43 |
|
|
2019
Q2 | $1.18M | Sell |
16,181
-60
| -0.4% | -$4.72K | 0.27% | 52 |
|
|
2019
Q1 | $1.31M | Buy |
16,241
+161
| +1% | +$13.2K | 0.31% | 45 |
|
|
2018
Q4 | $1.48M | Sell |
16,080
-276
| -2% | -$24.3K | 0.4% | 32 |
|
|
2018
Q3 | $1.55M | Sell |
16,356
-174
| -1% | -$16.5K | 0.38% | 37 |
|
|
2018
Q2 | $1.53M | Sell |
16,530
-454
| -3% | -$44.3K | 0.36% | 40 |
|
|
2018
Q1 | $1.61M | Sell |
16,984
-2,225
| -12% | -$244K | 0.41% | 38 |
|
|
2017
Q4 | $1.86M | Sell |
19,209
-395
| -2% | -$37.2K | 0.54% | 33 |
|
|
2017
Q3 | $1.74M | Sell |
19,604
-2,386
| -11% | -$182K | 0.56% | 34 |
|
|
2017
Q2 | $1.59M | Buy |
21,990
+3,872
| +21% | +$260K | 0.59% | 35 |
|
|
2017
Q1 | $1.18M | Sell |
18,118
-561
| -3% | -$35.3K | 0.47% | 45 |
|
|
2016
Q4 | $1.17M | Buy |
+18,679
| New | +$1.14M | 0.65% | 38 |
|
Other funds holding ABBV
VCM
VPM
Lee Financial's ABBV Position: Q1 2026 in Review
Lee Financial reduced its AbbVie (ABBV) stake by 20% in Q1 2026, selling an estimated $476K and leaving 8,784 shares worth $1.91M. The position accounts for 0.27% of the portfolio, ranked #38.
Lee Financial first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.91M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Lee Financial held 8,784 shares of AbbVie worth $1.91M as of Q1 2026.
- Lee Financial sold 2,147 AbbVie shares in Q1 2026, an estimated $476K.
- AbbVie made up 0.27% of Lee Financial's portfolio in Q1 2026, its #38 holding.
- Lee Financial first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
- Lee Financial's AbbVie position peaked at $2.91M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Lee Financial's 13F filing for Q1 2026, filed 13 Apr 2026.